Tango Therapeutics (TNGX) News Today $20.24 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$20.24 0.00 (-0.02%) As of 05/22/2026 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TNGX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period A Look At Tango Therapeutics (TNGX) Valuation After Wider Losses And Boardroom ChangesMay 22 at 7:32 AM | finance.yahoo.comTango Therapeutics, Inc. (NASDAQ:TNGX) Receives Consensus Rating of "Moderate Buy" from BrokeragesMay 20, 2026 | americanbankingnews.comPiper Sandler downgrades Tango Therapeutics (TNGX)May 17, 2026 | msn.comTango Therapeutics (NASDAQ:TNGX) Stock Price Down 14.4% - What's Next?May 17, 2026 | americanbankingnews.comTNGX stock crashes 20% after reporting $0 revenue in Q1 — but analysts still see massive upsideMay 15, 2026 | msn.comJefferies downgrades Tango Therapeutics (TNGX)May 15, 2026 | msn.comVanguard Group Inc. Has $59.81 Million Holdings in Tango Therapeutics, Inc. $TNGXMay 15, 2026 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Given New $33.00 Price Target at WedbushMay 15, 2026 | americanbankingnews.comTango Therapeutics (NASDAQ:TNGX) Given New $55.00 Price Target at Leerink PartnersMay 15, 2026 | americanbankingnews.comTango Therapeutics, Inc.: Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business HighlightsMay 14, 2026 | finanznachrichten.deTango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business HighlightsMay 13, 2026 | globenewswire.comStifel Remains Bullish on Tango Therapeutics (TNGX)May 10, 2026 | insidermonkey.comTango Therapeutics (NASDAQ:TNGX) Insider Adam Crystal Sells 27,000 SharesMay 6, 2026 | insidertrades.comAdam Crystal Sells 27,000 Shares of Tango Therapeutics (NASDAQ:TNGX) StockMay 5, 2026 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Stock Price Up 7.1% - Time to Buy?May 4, 2026 | marketbeat.comTango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 4, 2026 | globenewswire.comTango Therapeutics (TNGX) Expected to Announce Quarterly Earnings on MondayMay 4, 2026 | marketbeat.comWhy this CEO is confident his drug can top 'unprecedented' pancreatic cancer resultsApril 30, 2026 | msn.comTango Therapeutics (NASDAQ:TNGX) Trading Down 9.7% - Here's What HappenedApril 29, 2026 | marketbeat.comTango Therapeutics (TNGX) price target increased by 11.68% to 24.38April 28, 2026 | msn.comStifel Nicolaus Issues Positive Forecast for Tango Therapeutics (NASDAQ:TNGX) Stock PriceApril 27, 2026 | marketbeat.comTango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Rating of "Moderate Buy" by BrokeragesApril 25, 2026 | marketbeat.comIs Tango Therapeutics (TNGX) Building the Right Leadership Mix to Navigate Complex Oncology Pipelines?April 20, 2026 | finance.yahoo.comTango Therapeutics (NASDAQ:TNGX) Insider Adam Crystal Sells 38,460 SharesApril 17, 2026 | insidertrades.comTango Therapeutics Sub, Inc: Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of VopimetostatApril 16, 2026 | finanznachrichten.deTango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of VopimetostatApril 15, 2026 | globenewswire.comHealthcare quant check: RLAY and TNGX lead Seeking Alpha’s top picks ahead of Q1 earningsApril 7, 2026 | seekingalpha.comStifel and Jefferies raise targets on Tango Therapeutics (TNGX)April 6, 2026 | msn.comCanaccord Genuity initiates coverage of Tango Therapeutics (TNGX) with buy recommendationApril 3, 2026 | msn.comTango a new Buy at Canaccord Genuity on 2026 catalystsApril 2, 2026 | msn.comTango Therapeutics is the best performing healthcare stock in MarchMarch 30, 2026 | msn.comTango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day SurgeMarch 30, 2026 | fool.comEvaluating Tango Therapeutics (TNGX) Rich Valuation After Recent Share Price MomentumMarch 29, 2026 | finance.yahoo.comTango Therapeutics (NASDAQ:TNGX) Insider Sells $241,320.00 in StockMarch 29, 2026 | insidertrades.comTango Therapeutics (TNGX) price target increased by 32.09% to 20.06March 28, 2026 | msn.comThis stock is up 1,229% in just the past year, but don’t bet your retirement money on itMarch 27, 2026 | msn.comTango Therapeutics (TNGX) sees cautious analyst optimism following earningsMarch 13, 2026 | msn.comWedbush Reaffirms Outperform Rating for Tango Therapeutics (TNGX)March 10, 2026 | insidermonkey.comX4 Pharmaceuticals, Immuneering and Tango Therapeutics Are Getting New Analyst AttentionMarch 9, 2026 | 247wallst.comTango Therapeutics (TNGX) Soars 52% on Buy RecoMarch 7, 2026 | insidermonkey.comTango Therapeutics: I'm Not Buying Into Latest Rally, Despite PRMT5 PromiseMarch 6, 2026 | seekingalpha.comTango Therapeutics (TNGX) Hits All-Time High as Analyst Turns BullishMarch 5, 2026 | msn.comTango Therapeutics, Up 39% This Year, Surges Again On Another Cancer PactMarch 5, 2026 | investors.comInvestment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC FilingMarch 4, 2026 | fool.comEarnings To Watch: Tango Therapeutics Inc (TNGX) Reports Q4 2025 ResultMarch 4, 2026 | finance.yahoo.comTango Therapeutics (NASDAQ:TNGX) Insider Adam Crystal Sells 54,345 SharesFebruary 28, 2026 | insidertrades.comMizuho initiates coverage of Tango Therapeutics (TNGX) with outperform recommendationFebruary 23, 2026 | msn.comTango Therapeutics to Report Fourth Quarter 2025 Financial Results and Participate in Three Upcoming Investor ConferencesFebruary 18, 2026 | markets.businessinsider.comMost shorted stocks with up to $2B market cap as of mid-FebruaryFebruary 17, 2026 | msn.comGuggenheim Keeps Their Buy Rating on Tango Therapeutics (TNGX)February 8, 2026 | theglobeandmail.com Get Tango Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNGX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Videos TNGX Media Mentions By Week TNGX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNGX News Sentiment▼-0.200.45▲Average Medical News Sentiment TNGX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNGX Articles This Week▼24▲TNGX Articles Average Week Get the Latest News and Ratings for TNGX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Tango Therapeutics and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AXSM News Today RDY News Today ARWR News Today ELAN News Today CYTK News Today ABVX News Today PRAX News Today KRYS News Today IBRX News Today NUVL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNGX) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tango Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tango Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
